Replies to post #17619 on Abet Chichi2 (Chichi2)

[tomtomboombang]

AMSG - AmSurg Corp-AMSG our healthcare services Stock To Watch in 2005-
opinion @ TWPT steady - AMSG highly focused approach results in improved efficiency, better outcomes and lower capital requirements compared to term eps growth of 20-22%. Gastroenterology remains the most attractive de novo development area, with ophthalmology growth increasing with population aging and abundant acquisition opportunities. We are confident in the company's ability to drive long-term eps growth of 20-22% and we expect.. ... total organic revenue growth of 12%, we believe upside to these estimates exists

--------------
AmSurg Corp-AMSG initiated with a Sec Perform tgt $28

opinion @ RBCM
We believe AMSG can maintain solid mid-to high-single-digits organic volume growth driven by growth in colonoscopy and cataract-removal surgeries.